期刊
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
卷 1817, 期 5, 页码 838-848出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.bbabio.2012.03.005
关键词
Mitochondria; H+-ATP synthase; Liver; Translational control; Human development; Pathology
资金
- Ministerio de Educacion [AP2007-03035]
- JAE-CSIC
- Ministerio de Educacion y Ciencia [BFU2010-18903]
- Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), ISCIII
- Comunidad de Madrid, Spain [S2011/BMD-2402]
- Fundacion Ramon Areces
The mitochondrial H+-ATP synthase is a bottleneck component in the provision of metabolic energy by oxidative phosphorylation. The expression of its catalytic subunit (beta-F1-ATPase) is stringently controlled at post-transcriptional levels during oncogenesis. the cell cycle and in development. Here we show that miR-127-5p targets the 3'UTR of beta-F1-ATPase mRNA (beta-mRNA) significantly reducing its translational efficiency without affecting beta-mRNA abundance. Despite the reduced expression of beta-F1-ATPase in most human carcinomas, we observed no expression of miR-127-5p in different human cancer cell lines, minimizing the potential role of miR-127-5p as a regulator of the bioenergetic activity of mitochondria in cancer. In contrast, miR-127-5p is highly over-expressed in the human fetal liver. Consistent with previous findings in the rat, the expression of beta-F1-ATPase in the human liver also seems to be controlled at post-transcriptional levels during development, what might suggest a role for miR-127-5p in controlling beta-mRNA translation and thus in defining the bioenergetic activity of human liver mitochondria. Moreover, immunolocalization techniques and subcellular fractionation experiments using different antibodies against beta-F1-ATPase reveal that the ectopic expression of beta-F1-ATPase at the cell surface of the hepatocytes and HepG2 cells is negligible or stands for scrutiny. (C) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据